Marks significant expansion of initiative to help health systems access critical, at-risk medications for patients

Conshohocken, Pa. (Feb. 6, 2025) – Cencora, a global healthcare company, has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with reliable access to critical medications, including those at risk of going on shortage. Nearly 200 medications – including several oncology treatments – are now available through the program, which represents an increase of more than 350% since the program launched in 2021. 

More than 99% of hospital and health system pharmacists reported  experiencing drug shortages in 2023. As drug shortages continue to force hospitals to expend additional resources, including the administrative burden to find, procure and administer alternative drugs, Cencora’s sure supply program enables access to critical treatments spanning a wide range of therapeutic classes and disease states, including oncology, critical care, cardiovascular care and infectious diseases. Read More >